Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells
Open Access
- 1 September 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (3) , 174-181
- https://doi.org/10.1006/mthe.2001.0424
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Route of Administration Determines Induction of T-Cell-Independent Humoral Responses to Adeno-Associated Virus VectorsMolecular Therapy, 2000
- Humoral Immunity to Adeno-Associated Virus Type 2 Vectors following Administration to Murine and Nonhuman Primate MuscleJournal of Virology, 2000
- Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarizationNature Medicine, 1999
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Peroral gene therapy of lactose intolerance using an adeno-associated virus vectorNature Medicine, 1998
- Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectorsProceedings of the National Academy of Sciences, 1997
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinProceedings of the National Academy of Sciences, 1996
- Gene transfer into the mouse retina mediated by an adeno-associated viral vectorHuman Molecular Genetics, 1996
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994